Metformin Hydrochloride
Product Images NDC 70934-083

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 70934-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 083 30 Master Bottle Label Approval Rev B 02 19

70934 083 30 Master Bottle Label Approval Rev B 02 19
Label for Metformin Hydrochloride Extended-Release Tablets USP 750mg by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The package contains 30 tablets. Instructions and storage information are included, with a dosage note of 250 mg taken three times daily and storage between 15°-30°C (59°-86°F). The label also displays NDC 70934-083-30.*
FDA Label Image

Chemical Structure (Metformin 01)

Chemical Structure (Metformin 01)
Chemical structure of Metformin Hydrochloride showing atoms and bonds representing its molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.